Bharat Parenterals Ltd Closes Trading Window for Insider Trading

Bharat Parenterals Ltd has announced the closure of its trading window for dealing in equity shares, effective from July 1, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and will remain in effect until 48 hours after the declaration of the company's un-audited financial results (standalone and consolidated) for the quarter ended June 30, 2026. During this period, designated persons and their immediate relatives are prohibited from trading in the company's shares. The company will also facilitate the freezing of PANs of designated persons and their relatives at the depository portal. The date of the board meeting to approve these financial results will be intimated separately.